AdaptrialsSmart Trials. Bayesian Minds.

Create your account

Join the design workspace. Pick the role closest to your job — you will only see the actions your role is allowed to perform.

Full name*

Work email*

Organization*

City

Country*

Role

Your role decides which modules you can author, submit and approve.

Password*

At least 8 characters.

Confirm password*

By clicking “Create account” you confirm that you have read our Imprint and Data Protection information and agree to the processing of your data in accordance with the GDPR and our Terms & Conditions. You can withdraw your consent at any time with effect for the future.*

What each role can do

Permissions come from the platform governance matrix. Approvals always stay separated from authorship.

Biostatistician
Authors statistical design modules and submits them for review.
Clinical Lead
Authors clinical modules and approves design decisions.
DMC Member
Independent review; approves or rejects submitted modules.
Operations
Read-only oversight plus commenting.

This identity system includes short-lived email verification but no MFA or centralized token revocation. Those controls must be added before the platform holds real trial data.

The Bayesian decision copilot for adaptive clinical trials. Built by biostatisticians, for biostatisticians.

All systems operational

Platform

Decision Copilot
Bayesian Dashboard
Workflow
ADaM Generator
Audit Trail

Solutions

For Biostatisticians
For Clinical Biometrics
For CROs
For Emerging Biopharma

Compliance

FDA Adaptive Guidance 2019
ICH-E9(R1)
21 CFR Part 11
CDISC SDTM/ADaM
Security & Compliance

Resources

Knowledge Center
White Papers
Guides
Case Studies
Documentation

Company

About
Careers
Investor Relations
Request a Quote
Contact

© 2026 Adaptrials platform, Aomics GmbH, Königstein (T), Germany·Imprint·Data Protection·Terms & Conditions·

GDPRALCOA++21 CFR Part 11 controls

Disclaimer: Adaptrials software supports adaptive clinical trial design and statistical decision-making. Use of adaptive designs requires FDA review and approval via Special Protocol Assessment (SPA) or pre-submission consultation. Adaptrials outputs are decision-support tools and do not constitute regulatory advice. All submissions remain the responsibility of the sponsor.